Welcome to our dedicated page for Exponent SEC filings (Ticker: EXPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Exponent Inc filings document operating results, Regulation FD disclosures, capital-return actions, and governance matters for a science and engineering consulting company. Recent Form 8-K reports record quarterly financial results, dividend declarations, and share repurchase authorizations tied to the company’s common stock.
Proxy materials cover shareholder voting matters, director elections, executive compensation, pay-versus-performance tables, and board governance. The filing record also includes material-event disclosures related to leadership and corporate governance, along with capital-structure disclosures relevant to Exponent’s public-company reporting.
Exponent Inc. director Carol Lindstrom reported compensation-related equity activity and no open-market trades. She received a grant of 2,859 Restricted Stock Units (RSUs) that will cliff-vest on the day prior to the company’s next annual shareholder meeting. She also exercised 2,009 previously granted RSUs into 2,009 shares of Common Stock on a 1-for-1 basis, leaving no remaining RSUs from that prior grant. Following these transactions, she directly holds 9,405 shares of Common Stock. All transactions were recorded at a price of $0.00 per share, reflecting equity awards and a derivative conversion rather than market purchases or sales.
Exponent Inc. director George H. Brown received a grant of 2,859 Restricted Stock Units on June 4, 2026, which will cliff-vest before the company’s next annual shareholder meeting. On June 3, 2026, he also exercised 2,009 previously vested RSUs on a 1-for-1 basis into Common Stock, bringing his direct Common Stock holdings to 10,730 shares.
Exponent Inc director Karen A. Richardson reported equity compensation activity and updated holdings. She received a grant of 2,859 Restricted Stock Units (RSUs) that will cliff-vest on the day prior to the company’s next annual shareholder meeting, meaning all units vest at once.
She also exercised 2,009 previously vested RSUs into 2,009 shares of common stock on a 1-for-1 basis at no cash cost, leaving 2,009 common shares held directly. A separate entry shows 32,232 common shares held indirectly through a trust, reflecting additional ownership outside her personal account.
Exponent Inc director Debra Zumwalt reported routine equity compensation activity. On June 4, 2026, she received a grant of 2,859 Restricted Stock Units, which will cliff-vest before the company’s next annual shareholder meeting. On June 3, 2026, she exercised 2,009 RSUs into the same number of common shares on a 1:1 basis, bringing her direct common stock holdings to 31,830 shares.
Exponent Inc. director Paul R. Johnston exercised vested Restricted Stock Units into common stock in a routine compensation-related transaction. On June 3, 2026, 2,009 RSUs granted on June 5, 2025 converted into 2,009 shares of common stock on a 1-for-1 basis at no stated price.
Following the transaction, Johnston directly owns 62,940 shares of Exponent common stock. The filing shows an option/RSU exercise and conversion, with no open-market purchases or sales and no remaining RSU balance from this specific award.
Exponent Inc. Group Vice President James Bradley reported an open-market sale of 2,000 shares of Common Stock on May 26, 2026 at an average price of $57.465 per share. Following this transaction, he directly holds 1,105 shares of Exponent common stock.
Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 notice relating to the proposed sale of 2,000 shares of Common Stock (consisting of 1,580 and 420 restricted shares) with trade/reporting dates of 03/11/2026. The filing shows a listed market NASDAQ and a filing/report date of 05/26/2026.
EXPO files a Form 144 notice reporting proposed sales of restricted common stock.
The filing lists three restricted stock lots of 594, 568 and 510 shares with grant dates 03/11/2022, 03/11/2026 and 03/12/2021
Exponent Inc. Group Vice President Richard Reiss reported an open-market sale of 1,672 shares of Common Stock on May 19, 2026 at an average price of $58.6496 per share.
After this transaction, he directly holds 2,288 shares of Exponent common stock.
Exponent Inc. President & CEO Catherine Corrigan reported an option exercise and related share sales. On May 15, 2026, she exercised options for a total of 5,606 shares of common stock at strike prices of $29.05 and $25.405 per share, converting derivative awards into regular shares.
On the same date, she sold 4,194 shares of common stock in open-market transactions at an average price of $54.0595 per share. A footnote states these sales were made to cover the option exercise price and taxes, indicating a routine liquidity event rather than a purely discretionary sale. After these transactions, Corrigan directly owns 105,218 shares of Exponent common stock.